Founders

Richard Mead is a Senior Lecturer (associate professor) at the Sheffield Institute for Translational Neuroscience. He has extensive experience in preclinical drug discovery in academia and industry with a track record of taking compounds through preclinical programs to nomination for clinical development. He has previously identified an electrophilic Nrf2 activator which obtained orphan designation with the EMA for MND. He is a named inventor on 38 patents in 5 families, has authored 20 scientific publications and raised funding of £9M as primary investigator and founder.

Pamela Shaw is the Vice President and Head of the Faculty of Medicine and Dentistry, University of Sheffield and Director of the Sheffield Institute for Translational Neuroscience (SITraN). She is also Director of the NIHR Biomedical Research Centre Translational Neuroscience for Chronic Neurological Disorders. Professor Shaw is a clinician scientist and world leading expert on mechanisms and treatment of motor neuron disease. She has published over 425 papers and has an H Index of 88.